Current perspectives in the pharmacological studies of store-operated Ca2+ entry blockers

Japanese Journal of Pharmacology

Volumn 81, Issue 3, 1999, Pages 253-258

  Leung, Yuk Man ^a   Kwan, Chiu Yin ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Calcium channel; Ginsenoside; LOE 908; LU52396; SK and F 76365; Tetrandrine

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 2 (3,4 DIHYDRO 6,7 DIMETHOXY 1 ISOQUINOLINYL) 2 PHENYL N,N BIS[2 (2,3,4 TRIMETHOXYPHENYL)ETHYL]ACETAMIDE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; GINSENG SAPONIN; GINSENOSIDE; LU 52396; MANGANESE; TETRANDRINE; UNCLASSIFIED DRUG;

ANIMAL CELL; CATION TRANSPORT; HUMAN; HUMAN CELL; NONHUMAN; REVIEW;

ACETAMIDES; ALKALOIDS; ANIMALS; BENZYLISOQUINOLINES; CALCIUM CHANNEL BLOCKERS; HUMANS; IMIDAZOLES; ISOQUINOLINES; PANAX; PIPERAZINES; PLANTS, MEDICINAL; SAPONINS;

EID: 0032763242     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.81.253     Document Type: Review

References (40)

1. 2+ influx following receptor activation. Trends Pharmacol Sci 12, 289-292 (1991)
2. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol Sci 15, 77-83 (1994)
3. Felder CC, Singer-Lahat D and Mathes C: Voltage-independent calcium channels. Regulation by receptors and intracellular calcium stores. Biochem Pharmacol 48, 1997-2004 (1994)
4. 2+ channels. Cell Calcium 19, 269-279 (1996)
5. Putney JW Jr: Capacitative calcium entry revisited. Cell Calcium 11, 611-624 (1990)
6. Berridge MJ: Capacitative calcium entry. Biochem J 312, 1-11 (1995)
7. Darby PJ, Kwan CY and Daniel EE: Use of calcium pump inhibitors in the study of calcium regulation in smooth muscle. Biol Signals 2, 293-304 (1993)
8. Kwan CY and Putney JW Jr: Uptake and intracellular sequestration of divalent cations in resting and methacholine-stimulated mouse lacrimal acinar cells. J Biol Chem 265, 678-684 (1990)
9. 2+ stores and activates an influx pathway for divalent cations in HL-60 cells. J Biol Chem 267, 2318-2324 (1992)
10. Leung YM, Kwan CY and Loh TT: Dual effects of tetrandrine on cytosolic calcium in human leukaemic HL-60 cells: intracellular calcium release and calcium entry blockade. Br J Pharmacol 113, 767-774 (1994)
11. 2+ influx in rat hepatocytes. Identification and characterization using manganese. J Biol Chem 265, 17486-17492 (1990)
12. + channels. Life Sci 56, 295-306 (1995)
13. Kwan CY, Deng HW and Guan YY: Tetrandrine is not a selective calcium channel blocker in vascular smooth muscle. Acta Pharmacol Sin 13, 385-390 (1992)
14. Takemura H, Kwan CY and Ohshika H: Calcium antagonistic actions of tetrandrine depend on cell types. Res Commun Mol Pathol Pharmacol 90, 59-68 (1995)
15. 2+ antagonist: effects and mechanisms of action in vascular smooth muscle cells. J Pharmacol Exp Ther 273, 32-39 (1995)
16. Su JY: Mechanisms of action of 7-O-ethyl tetrandrine in isolated vascular smooth muscle of the rabbit aorta. Naunyn Schmiedebergs Arch Pharmacol 347, 445-451 (1993)
17. Ma LJ, Yin ZZ and Liu GZ: Effect of hernandezine on platelet aggregation and its mechanism of action. Chin J Pharmacol Toxicol 5, 41-43 (1991)
18. 2+ influx of pig basilar artery. Acta Pharmacol Sin 13, 412-416 (1993)
19. Leung YM, Berdik M, Kwan CY and Loh TT: Effects of tetrandrine and closely related bis-benzylisoquinoline compounds on cytosolic calcium: a structure-activity relationship study. Clin Exp Pharmacol Physiol 23, 653-659 (1996)
20. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, Leigh BK, McCarthy SA, Moores KE and Rink TJ: SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 271, 515-522 (1990)
21. 2+ transport pathways in thymic lymphocytes by econazole, miconazole, and SKF 96365. Am J Physiol 264, C654-C662 (1993)
22. Tornquist K: Activation of calcium entry by cyclopiazonic acid in thyroid FRTL-5 cells. Cell Calcium 14, 411-417 (1993)
23. 2+ in intact valvular endothelium from rabbits. Am J Physiol 270, H837-H848 (1996)
24. Leung YM, Kwan CY and Loh TT: Dual effects of SK&F 96365 in human leukemic HL-60 cells: inhibition of calcium entry and activation of a novel cation influx pathway. Biochem Pharmacol 51, 605-612 (1996)
25. 2+ entry in MDCK renal epithelial cells. Mol Pharmacol 45, 300-305 (1994)
26. Schwarz G, Droogmans G and Nilius B: Multiple effects of SK&F 96365 on ionic currents and intracellular calcium in human endothelial cells. Cell Calcium 15, 45-54 (1994)
27. Krautwurst D, Hescheler J, Arndts D, Losel W, Hammer R and Schultz G: Novel potent inhibitor of receptor-activated non-selective cation currents in HL-60 cells. Mol Pharmacol 43, 655-659 (1993)
28. Krautwurst D, Degtiar VE, Schultz G and Hescheler J: The isoquinoline derivative LOE 908 selectively blocks vasopressin-activated nonselective cation currents in A7r5 aortic smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol 349, 301-307 (1994)
29. Franzius D, Hoth M and Penner R: Non-specific effects of calcium entry antagonists in mast cells. Pflugers Arch 428, 433-438 (1994)
30. 2+ entry pathway in human endothelial cells by the isoquinoline derivative LOE 908. Br J Pharmacol 119, 702-706 (1996)
31. 2+ influx. Eur J Pharmacol 289, 23-31 (1995)
32. 2+-entry antagonist LU 52396: its inhibitory activity depends on the activation state of the cells. Cell Calcium 22, 91-97 (1997)
33. Guan YY, He H and Chen JX: Effect of total saponins of Panax notoginseng on contraction of rabbit aortic strips. Acta Pharmacol Sin 6, 267-269 (1985)
34. Guan YY: Effect of total saponins of Panax notoginseng on transmitter release at mouse motor nerve terminal. Chin Pharmacol Bull 3, 137-140 (1987)
35. Guan YY, Kwan CY, He H and Daniel EE: Inhibition of norepinephrine-induced contractile responses of canine mesenteric artery by plant total saponins. Blood vessels 25, 312-315 (1988)
36. 2+ accumulation by vascular smooth muscle microsomes. Biochem Arch 6, 367-373 (1990)
37. 2+ channels in vascular smooth muscle. Acta Pharmacol Sin 15, 392-398 (1994)
38. Kwan CY, Guan YY and Deng HW: Calcium antagonistic and antioxidant effects of ginseng saponins. In Proceedings of the International Ginseng Conference, Edited by Bailey WB, Whitehead C, Proctor JTA and Kyl JT, pp 318-323, Simon Fraser University, Bunaby, Canada (1995)
39. st European Ginseng Congress, Edited by Weber C, Seuske D and Imhof S, pp 45-53, Philipps-Universität, Marburg, Germany (1998)
40. Chen X, Gillis CN and Moalli R: Vascular effets of ginsenosides in vitro. Br J Pharmacol 82, 485-491 (1984)